Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway
Authors:
- 11 December 2019
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 40 (1) , 203-210
Abstract
Mannose-binding lectin (MBL)-associated serine protease-2 (MASP-2) is an indispensable enzyme for the activation of the lectin pathway of complement. Its deficiency is classified as a primary immunodeficiency associated to pyogenic bacterial infections, inflammatory lung disease, and autoimmunity. In Europeans, MASP-2 deficiency, due to homozygosity for c.359A > G (p.D120G), occurs in 7 to 14/10,000 individuals. We analyzed the presence of the p.D120G mutation in adults (increasing the sample size of our previous studies) and children. Different groups of patients (1495 adults hospitalized with community-acquired pneumonia, 186 adults with systemic lupus erythematosus, 103 pediatric patients with invasive pneumococcal disease) and control individuals (1119 healthy adult volunteers, 520 adult patients without history of relevant infectious diseases, and a pediatric control group of 311 individuals) were studied. Besides our previously reported MASP-2-deficient healthy adults, we found a new p.D120G homozygous individual from the pediatric control group. We also reviewed p.D120G homozygous individuals reported so far: a total of eleven patients with a highly heterogeneous range of disorders and nine healthy controls (including our four MASP-2-deficient individuals) have been identified by chance in association studies. Individuals with complete deficiencies of several pattern recognition molecules of the lectin pathway (MBL, collectin-10 and collectin-11, and ficolin-3) as well as of MASP-1 and MASP-3 have also been reviewed. Cumulative evidence suggests that MASP-2, and even other components of the LP, are largely redundant in human defenses and that individuals with MASP-2 deficiency do not seem to be particularly prone to infectious or autoimmune diseases.Keywords
Funding Information
- Instituto de Salud Carlos III (FIS PI13/01456, FIS PI16/00759, FIS PI13/01729)
- Grupo DISA (OA18/017)
- Sociedad Española de Neumología y Cirugía Torácica
- Universidad de Las Palmas de Gran Canaria
This publication has 56 references indexed in Scilit:
- Mannan-Binding Lectin-Associated Serine Protease (MASP)-1 Is Crucial for Lectin Pathway Activation in Human Serum, whereas neither MASP-1 nor MASP-3 Is Required for Alternative Pathway FunctionThe Journal of Immunology, 2012
- The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal InfectionPLOS Pathogens, 2012
- Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndromeNature Genetics, 2011
- Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary ImmunodeficiencyFrontiers in Immunology, 2011
- MASP1 Mutations in Patients with Facial, Umbilical, Coccygeal, and Auditory Findings of Carnevale, Malpuech, OSA, and Michels SyndromesThe American Journal of Human Genetics, 2010
- Infections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyClinical Microbiology Reviews, 2010
- MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinomaJournal of Viral Hepatitis, 2008
- Low clinical penetrance of mannose-binding lectin–associated serine protease 2 deficiencyJournal of Allergy and Clinical Immunology, 2006
- The mannan-binding lectin pathway and lung disease in cystic fibrosis—dysfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifierClinical Immunology, 2006
- Functional MASP2 single nucleotide polymorphism plays no role in psoriasisBritish Journal of Dermatology, 2005